Literature DB >> 16738270

Body-mass index and symptoms of gastroesophageal reflux in women.

Brian C Jacobson1, Samuel C Somers, Charles S Fuchs, Ciarán P Kelly, Carlos A Camargo.   

Abstract

BACKGROUND: Overweight and obese persons are at increased risk for gastroesophageal reflux disease. An association between body-mass index (BMI)--the weight in kilograms divided by the square of the height in meters - and symptoms of gastroesophageal reflux disease in persons of normal weight has not been demonstrated.
METHODS: In 2000, we used a supplemental questionnaire to determine the frequency, severity, and duration of symptoms of gastroesophageal reflux disease among randomly selected participants in the Nurses' Health Study. After categorizing women according to BMI as measured in 1998, we used logistic-regression models to study the association between BMI and symptoms of gastroesophageal reflux disease.
RESULTS: Of 10,545 women who completed the questionnaire (response rate, 86 percent), 2310 (22 percent) reported having symptoms at least once a week, and 3419 (55 percent of those who had any symptoms) described their symptoms as moderate in severity. We observed a dose-dependent relationship between increasing BMI and frequent reflux symptoms (multivariate P for trend <0.001). As compared with women who had a BMI of 20.0 to 22.4, the multivariate odds ratios for frequent symptoms were 0.67 (95 percent confidence interval, 0.48 to 0.93) for a BMI of less than 20.0, 1.38 (95 percent confidence interval, 1.13 to 1.67) for a BMI of 22.5 to 24.9, 2.20 (95 percent confidence interval, 1.81 to 2.66) for a BMI of 25.0 to 27.4, 2.43 (95 percent confidence interval, 1.96 to 3.01) for a BMI of 27.5 to 29.9, 2.92 (95 percent confidence interval, 2.35 to 3.62) for a BMI of 30.0 to 34.9, and 2.93 (95 percent confidence interval, 2.24 to 3.85) for a BMI of 35.0 or more. Even in women with a normal baseline BMI, an increase in BMI of more than 3.5, as compared with no weight changes, was associated with an increased risk of frequent symptoms of reflux (odds ratio, 2.80; 95 percent confidence interval, 1.63 to 4.82).
CONCLUSIONS: BMI is associated with symptoms of gastroesophageal reflux disease in both normal-weight and overweight women. Even moderate weight gain among persons of normal weight may cause or exacerbate symptoms of reflux. Copyright 2006 Massachusetts Medical Society.

Entities:  

Mesh:

Year:  2006        PMID: 16738270      PMCID: PMC2782772          DOI: 10.1056/NEJMoa054391

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  25 in total

1.  No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study.

Authors:  J Lagergren; R Bergström; O Nyrén
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

2.  Obesity is an independent risk factor for GERD symptoms and erosive esophagitis.

Authors:  Hashem B El-Serag; David Y Graham; Jessie A Satia; Linda Rabeneck
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

3.  The burden of selected digestive diseases in the United States.

Authors:  Robert S Sandler; James E Everhart; Mark Donowitz; Elizabeth Adams; Kelly Cronin; Clifford Goodman; Eric Gemmen; Shefali Shah; Aida Avdic; Robert Rubin
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

4.  Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization.

Authors:  C J Henke; T R Levin; J M Henning; L P Potter
Journal:  Am J Gastroenterol       Date:  2000-03       Impact factor: 10.864

5.  Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST).

Authors:  V Stanghellini
Journal:  Scand J Gastroenterol Suppl       Date:  1999

6.  Obesity and estrogen as risk factors for gastroesophageal reflux symptoms.

Authors:  Magnus Nilsson; Roar Johnsen; Weimin Ye; Kristian Hveem; Jesper Lagergren
Journal:  JAMA       Date:  2003-07-02       Impact factor: 56.272

7.  Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications.

Authors:  Howard Hampel; Neena S Abraham; Hashem B El-Serag
Journal:  Ann Intern Med       Date:  2005-08-02       Impact factor: 25.391

8.  Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project.

Authors:  Liam Murray; Brian Johnston; Athene Lane; Ian Harvey; Jenny Donovan; Prakash Nair; Richard Harvey
Journal:  Int J Epidemiol       Date:  2003-08       Impact factor: 7.196

9.  Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma.

Authors:  Anna H Wu; Chiu-Chen Tseng; Leslie Bernstein
Journal:  Cancer       Date:  2003-09-01       Impact factor: 6.860

10.  Prevalence and trends in obesity among US adults, 1999-2000.

Authors:  Katherine M Flegal; Margaret D Carroll; Cynthia L Ogden; Clifford L Johnson
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

View more
  156 in total

1.  Combined paraesophageal hernia repair and partial longitudinal gastrectomy in obese patients with symptomatic paraesophageal hernias.

Authors:  John H Rodriguez; Matthew Kroh; Kevin El-Hayek; Poochong Timratana; Bipan Chand
Journal:  Surg Endosc       Date:  2012-06-03       Impact factor: 4.584

2.  Is hormone replacement therapy in post-menopausal women associated with a reduced risk of oesophageal cancer?

Authors:  Shyam Menon; Peter Nightingale; Nigel Trudgill
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

Review 3.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

4.  The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model.

Authors:  Chung Yin Kong; Kevin J Nattinger; Tristan J Hayeck; Zehra B Omer; Y Claire Wang; Stuart J Spechler; Pamela M McMahon; G Scott Gazelle; Chin Hur
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-19       Impact factor: 4.254

Review 5.  Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation.

Authors:  Arne Kandulski; Peter Malfertheiner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-22       Impact factor: 46.802

6.  Bravo pH Testing On and Off Treatment With Immediate-Release Omeprazole: A Review of Findings Presented at the 71st Annual Scientific Meeting of the American College of Gastroenterology October 20-25, 2006 Las Vegas, Nev.

Authors:  Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-01

7.  Hypopharyngeal multichannel intraluminal impedance leads to the promising outcome of antireflux surgery in Japanese population with laryngopharyngeal reflux symptoms.

Authors:  Takeshi Suzuki; Yosuke Seki; Yoshitaka Okamoto; Toshitaka Hoppo
Journal:  Surg Endosc       Date:  2017-12-07       Impact factor: 4.584

Review 8.  Surgical Anti-Reflux Options Beyond Fundoplication.

Authors:  Dan Azagury; John Morton
Journal:  Curr Gastroenterol Rep       Date:  2017-07

9.  Two thousand transhiatal esophagectomies: changing trends, lessons learned.

Authors:  Mark B Orringer; Becky Marshall; Andrew C Chang; Julia Lee; Allan Pickens; Christine L Lau
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

10.  Effect of high fat-diet and obesity on gastrointestinal motility.

Authors:  Mazen Al Mushref; Shanthi Srinivasan
Journal:  Ann Transl Med       Date:  2013-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.